| 标题 |
D29-04 AGMB-447, an Inhaled Lung-Restricted TGFβR1/ALK5 Inhibitor Intended for the Treatment of Idiopathic Pulmonary Fibrosis, Shows Robust Anti-Fibrotic Activity and Target Engagement in Preclinical Species and Healthy Subjects |
| 网址 | |
| DOI |
10.1093/ajrccm/aamag162.2864
doi
|
| 其它 |
期刊:American Journal of Respiratory and Critical Care Medicine 作者:G De Wilde; A Sáez-Borderías; R Bosser; P -J Stiers; T Van Kaem; et al 出版日期:2026-05-19 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)